Authors: Fine, BA Munoz, AK Litz, CE Gershenson, DM

Citation: Ba. Fine et al., Primary medical management of recurrent aggressive angiomyxoma of the vulva with a gonadotropin-releasing hormone agonist, GYNECOL ONC, 81(1), 2001, pp. 120-122

Authors: Fine, BA Valente, PT Feinstein, GI Dey, T

Citation: Ba. Fine et al., VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma, GYNECOL ONC, 76(1), 2000, pp. 33-39

Authors: Poplin, EA Liu, PY Delmore, JE Wilczynski, S Moore, DF Potkul, RK Fine, BA Hannigan, EV Alberts, DS

Citation: Ea. Poplin et al., Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: A Southwest Oncology Group study, GYNECOL ONC, 74(3), 1999, pp. 432-435

Authors: Fine, BA Greendale, K

Citation: Ba. Fine et K. Greendale, Professional development, GUIDE TO GENETIC COUNSELING, 1998, pp. 331-345